Vascular endothelial cells are one of the major biological targets of reactive oxygen species (ROS) in ischemiareperfusion, diabetes, hypercholesterolemia and inflammation. Accumulated evidence has shown that tetrahydrobiopterin (BTI4), which is an essential cefaclor for nitric oxide synthase (NOS) activity, protected the cells against ROS and nitric oxide (NO) toxicities. Although NOS releases NO, which regulates vascular tone and immune surveillance under normal conditions, NOS also produces superoxide anion and hydrogen peroxide when BH4 is decreased, suggesting the possibility that NOS is a source of ROS under pathological conditions. Since 15114 is easily oxidized by ROS, oxidative stress may induce ROS release from NOS by the decomposition of BH4. ÖH4 also has an antioxidative activity and scavenging activity for ROS. In this review, the role of BH4 in the function of' NOS, and the mechanisms underlying the protective effect of BFU against ROS-and/or NO-induced endothelial cell injury will be discussed.
Introduction
which the enzyme OTP cyclohydrolase 1 catalyzes the rate-limiting step, or via a salvage pathway that utilizes sepiaplerin during an intermediate step (8, 9) . Interestingly, purified NOS 1 from the brain has been shown to produce reactive oxygen species (ROS) when ΒΠ4) and/or 1.-arginine are decreased ( 10, 1 1).
Recently, the production of ROS by endothelial isolbrm NOS III has also been confirmed (12) (13) (14) (15) . NO reacts w ith ROS such as superoxide anion and hydrogen peroxide to form peroxynitrite, singlet oxygen and hydroxvl radical, which are more toxic species . Therefore, the simultaneous production of NO and ROS by NOS in the presence of suboplimal concentrations of Bi b may lead to cytotoxicity. The BIU content of cells may be lowered in the presence of ROS, since it is easily oxidized by ROS. Under pathological conditions such as hypercholesterolemia and diabetes mellitus, the BH4 content is likely to be decreased (20) (21) (22) (23) .
Therefore, it is possible that dysfunction of NOS may be an important factor in the development of many circulatory diseases. Importantly, pterins, including Bll-t, are putative antioxidants and radical scavengers (24) (25) (26) (27) (28) 
Dysfunction of NOS by oxidative stress and endothelial cell injury
Reactive oxygen species are implicated in the development of many diseases such as ischemia-reperfusion injury, inflammation and diabetes. NO has been shown to react highly with superoxide anion and hydrogen peroxide to produce cytotoxic species such as peroxynitrite and the hydroxyl radical (16) (17) (18) (19) . Although NO has been shown to attenuate ischemiareperfusion injury (29) , hypoxia-reoxygenation injury (30) and ROS-induced cytotoxicity (31) (32) (33) , there have also been many reports of the toxic effects of NO in pathologic conditions, including ischemia-reperfusion, inflammation and diabetes mellitus (34) (35) (36) . In 1994, in the process of examining whether NO, produced from endothelial cells during hydrogen peroxide treatment, modulates the hydrogen peroxide-induced cell injury, we found that N°-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NOS, reduces exogenous hydrogen peroxide-induced endothelial cell injury, but
, also an inhibitor of NO synthesis, does not, although both NOS inhibitors completely blocked the NOS activity (37). Heinzel et al. (10) reported that purified NOS I from the brain releases hydrogen peroxide instead of NO at low concentrations of L-arginine, a substrate for NO synthesis, or BH4, one of the cofactors for NO synthesis. Pou et al. (11) also showed that NOS I from brain produces superoxide anion. The production of superoxide anion by NOS I is inhibited by L-NAME, but not by L-NMA (10, 11). As for the mechanism of the protective effect of L-NAME on hydrogen peroxideinduced endothelial cell injury, we speculated that L-NAME inhibits the production of ROS by NOS III during oxidative stress-induced cell injury. In fact, NOS III has also been confirmed to release superoxide anion and hydrogen peroxide in the presence of suboptimal concentrations of BH4 (12) (13) (14) (15) . Moreover, there are some suggestive data indicating that the production of ROS from NOS III was inhibited by L-NAME. Pritchard et al. (38) showed that native low-density lipoprotein enhances superoxide generation from NOS III in human umbilical vein endothelial cells, and the generation of superoxide anion is inhibited by L-NAME. Cosentino and Katusic (39) reported that a decrease in BH4 causes production of hydrogen peroxide from NOS III in dog coronary arteries, and this production is prevented by L-NAME. We also showed that vascular endothelial cells activated by Ca 2 *-ionophore produce superoxide anion when the BH4 content in the cells is decreased, and the superoxide anion release is inhibited by L-NAME (40) . ]¡ several hours after addition in bovine aortic endothelial cells (43) . The increases in NOS activity are observed before lethal cell injury. Thus, NOS activity, which is measured by the conversion of L-arginine to L-citrulline, is stimulated during oxidative stress via an increase in [Ca 2 *]i before cell death (43) . Although it has not been determined whether NOS III produces NO or ROS before cell death, activation of NOS III before cell death may mainly produce ROS, since BH4 is easily oxidized by ROS. These observations supported our hypothesis that the production of ROS by NOS III is implicated in the hydrogen peroxide-induced vascular endothelial cell injury. Thus, BH4 could be the most important target of oxidative stress in the vascular endothelial cells. It is possible that dysfunction of NOS III accompanied by a decrease in the BH4 content causes a simultaneous release of ROS and NO, and that the dysfunction of the enzyme may be involved in the development of many diseases such as ischemia-reperfusion, hypercholesterolemia and diabetes. In fact, recent studies have shown the beneficial effects of BH4 on vascular endothelial cell function in human and various experimental models (44) (45) (46) (47) (48) (49) .
Protective effect of BH4 against ROS-induced cell injury
We found that BH4 strongly reduced hydrogen peroxide-induced cell injury in bovine aortic endothelial cells (50) . Pterins including BH4 have antioxidative activity and scavenging activity for ROS. Shen and Zhang (51) first demonstrated that BH4 has antioxidative activity by showing that BH4 inhibits dopamine autoxidation. Moreover, they suggested that the BH4/NADH:BH4 antioxidant system in rat phenochromocytoma (PC 12) cells has a protective effect against oxidative damage (52) . However, the reaction mechanism remains to be established. Kojima et al. (26) found that BH4 acts directly as a scavenger of superoxide anion generated by xanthine/xanthine oxidase or by rat macrophage/phorbol myristate acetate radicalgenerating systems, and that paraquat-induced cytotoxicity of cultured hepatocytes is suppressed by BH4. The superoxide anion-scavenging activity of BH4 seems to be stronger than that of ascorbic acid (26) . Using 2',7'-dichlorofluorescin, a hydroperoxide-sensitive dye, we showed that BH4 reduces hydrogen peroxide-induced intracellular oxidative stress (50) . In contrast, BH4 has been shown to give rise to superox-ide anion by autoxidation (53) . We also observed that BH4 generates 2',7'-dichlorofluorescin-detectable ROS in the absence of cells (unpublished data). Therefore, although whether or not extracellular BH4 scavenges ROS is still controversial, intracellular BHU seems mainly to play a role as a radical scavenger and/or antioxidant. Thus, BH4 has strong antioxidant activity, and protects various cells against oxidative stress. ROS are implicated in the development of many pathological states, such as ischemia-reperfusion injury, vascular dysfunction accompanying diabetes mellitus, hypercholesterolemia, inflammation and Parkinsonism. BH4 may be useful in the treatment of various diseases which are related to ROS, since BHU has antioxidative and ROS scavenging activities, and improves the dysfunction of NOS, as discussed in the iection of "Dysfunction of NOS by oxidative stress ir.d endothelial cell injury·."
Protective effect of tetrahydrobiopterin against NO-induced cell injury An inducible type of NOS is induced by hpopolysaccharide (LPS) and/or cytokines in various types of cells including vascular endothelial cells (54) , and this type of NOS continuously generates large amounts of NO. The large amounts of NO have been shown to induce lethal cell injury in the endothelial cells (55) (56) (57) . We and others have reported that NO donor S-nitroso-N-acetyl-DL-penicillamine (SNAP)-induced cell injury is inhibited by exogenous BH4 in HL-60 cells (58) and the vascular endothelial cells (59) . Although the mechanisms of NO-induced cell injury remain unclear, the toxicities of NO-donors have been shown to be reduced by treatment with catalase, but not with superoxide dismutase (SOD) (57, 59) . Thus, cytotoxicity induced by NO is likely to be mediated by endogenously produced hydrogen peroxide. In fact, Asahi et al. (60, 61) have shown that glutathione peroxidase, which is part of the intracellular hydrogen peroxide-scavenging system, is inactivated by NO. Intracellular glutathione (GSH) content may also be decreased by reaction of GSH with NO to form S-mtroso-glutathione (62, 63) . Depletion of GSH by GSH-depleting agents causes lethal cell injury, and the cytotoxicity is mediated by ROS (64) . Therefore, we speculated that endogenous production of hydrogen peroxide caused by the treatment with NO is likely to be involved in NO-induced cell injury, and that BH4 protects cells against NO cytotoxicity at least partially by the scavenging of hydrogen peroxide as discussed in the section "Protective effect of BH4 against ROSinduced cell injury."
As one of the mechanisms of protection by BH4 against NO cytotoxicity, Kojima et al. (58) argued that BH4 quenches NO, since BH4 reacts with 1,1-diphenyl-2-picrylhydrazyl, a stable radical, in an ethanol solution. Although those results are important, the investigation was indirect. Further studies are needed to examine in detail whether or not BH4 scavenges NO. The BH4 content is increased along with the induction of NOS II by treatment with LPS and/or cytokines in several types of cells (65, 66) . The expression of the mRNA for GTP-cyclohydrolase I, which is the ratelimiting enzyme for BH4 synthesis, is also increased (65, 66) . NOS II is composed of polypeptide homodimers under native conditions. Dimerization of NOS II requires the coincident presence of heme and BH4. Gross and Levi (67) reported that BH4 synthesis is an absolute requirement for the induction of NO synthesis by LPS in vascular smooth muscle cells. Nakayama et al. (68) also suggested that intracellular BH4 content was closely correlated with the induction of NOS II in vascular smooth muscle cells, and the intracellular availability of BH4 has been shown to limit the expression of active NOS II dimers (69, 70) . Thus, although it is believed that an increase in the BH4 content is required for the production of NO from inducible NOS, the role of the increased BH4 that accompanies NOS induction is not fully understood. We observed that an excess amount of BH4 is synthesized during NO production by NOS II in LPS-treated rat aorta (71). Mogi et al. (72) suggested that Β Ht has a selfprotective role in cytokine-induced apoptotic cell death in mouse osteoblastic cells. It is possible that BH4 plays a role in self-protection against the large amounts of NO produced by NOS II, as another function.
Conclusions
ROS are known to be implicated in many pathological states, such as ischemia-reperfusion injury, inflammatory diseases, diabetes mellitus and hypercholesterolemia. Generation of ROS by NOS accompanied by a decrease in the BH4 concentration was first reported for NOS I. Not only NOS I, but also NOS III, produces ROS when the BH4 concentration is decreased. BH4 seems to be one of the most important targets of oxidative stress in the vascular endothelial cells. The NOS dysfunction is prevented by exogenous BH4. Moreover, BH4 protects the cells against ROS-induced cell injury by scavenging ROS such as superoxide anion and hydrogen peroxide. Interestingly, BH4 also has a protective effect against NO-induced cytotoxicity. ΒΙΊ4 may be useful m the treatment of various diseases which are related to ROS and NO.
